Aspen CEO Stephen Saad (L) and South Africa Minister of Trade Ebrahim Patel

Rid­ing Covid-19 high, As­pen plans new ad­di­tions at South African pro­duc­tion site

Changes are com­ing to As­pen Phar­ma­care’s plant in Gqe­ber­ha, South Africa.

The com­pa­ny will open the largest anes­thet­ics man­u­fac­tur­ing line in the south­ern hemi­sphere at the same site that it fills and pack­ages the J&J Covid-19 vac­cine, the com­pa­ny’s CEO Stephen Saad told re­porters Mon­day.

The ex­pan­sion could gen­er­ate an­oth­er $542 mil­lion in rev­enue a year. In 2018, As­pen start­ed man­u­fac­tur­ing drugs for late-stage can­cer, au­toim­mune ill­ness­es and Parkin­son’s dis­ease. Just last year, it start­ed fill-fin­ish op­er­a­tions for the J&J jab.

Endpoints News

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters